1[1]Brozinick JT, Roberts BR, Dohm GL. Defective signaling through Akt-2 and -3 but not Akt-1 in insulin -resistant human skeletal muscle: potential role in insulin resistance. Diabetes,2003, 52:935-941
2[2]Wallace TM, Methews DR. The assessment of insulin resistance in man. Diabetic Med,2002,19:527-534
3[3]Roith DL, Yehiel Z. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care,2001,24:588-597
4[4]Clark SF, Molero JC, James DE. Release of insulin receptor substrate proteins from an intracellular complex coincides with the development of insulin resistance. J Biol Chem ,2000,275:3819-3826
5[5]Krook A, Bjornhalm M, Galuska D, et al.Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 2000,49:284-292
6[6]Haring HU. Pathogenisis of type 2 diabetes: are there common causes for insulin resistance and secretion failure. Exp Clin Endocrinol Diabetes,1999,107(suppl 2):s17-s23
7[7]Ciaraldi TP, Kong ASP, Chu NV, et al. Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects. Diabetes,2002, 51:30-36
8[8]Freid J, Everitt D, Boscia J. Rosiglitazone and hepatic failure. Ann Intern Med ,2000,132:164
4Ferroni P, Basili S, Falco A, et al. Platclet activation in type 2 diabetes mellitus [ J ]. J Thromb Haemost, 2004, 2 ( 8 ) : 1282.
5Vizioli L, Muscari S, Museari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases [J]. Int J Clin Pract, 2009, 63 (10) : 1509.
